A detailed history of Eqis Capital Management, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 4,714 shares of VRTX stock, worth $1.92 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
4,714
Previous 4,546 3.7%
Holding current value
$1.92 Million
Previous $2.13 Million 2.91%
% of portfolio
0.18%
Previous 0.18%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$460.0 - $505.78 $77,280 - $84,971
168 Added 3.7%
4,714 $2.19 Million
Q2 2024

Aug 13, 2024

SELL
$392.81 - $485.53 $9,820 - $12,138
-25 Reduced 0.55%
4,546 $2.13 Million
Q1 2024

May 14, 2024

BUY
$407.69 - $446.08 $311,067 - $340,359
763 Added 20.04%
4,571 $1.91 Million
Q4 2023

Feb 14, 2024

SELL
$343.0 - $410.68 $120,736 - $144,559
-352 Reduced 8.46%
3,808 $1.55 Million
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $114,643 - $122,873
339 Added 8.87%
4,160 $1.45 Million
Q2 2023

Aug 14, 2023

SELL
$314.42 - $351.91 $232,670 - $260,413
-740 Reduced 16.22%
3,821 $1.34 Million
Q1 2023

May 15, 2023

SELL
$283.23 - $323.1 $135,667 - $154,764
-479 Reduced 9.5%
4,561 $1.44 Million
Q4 2022

Feb 14, 2023

SELL
$285.76 - $321.48 $16,002 - $18,002
-56 Reduced 1.1%
5,040 $1.46 Million
Q3 2022

Oct 24, 2022

BUY
$273.83 - $305.53 $90,363 - $100,824
330 Added 6.92%
5,096 $1.48 Million
Q2 2022

Aug 08, 2022

SELL
$234.96 - $292.55 $75,892 - $94,493
-323 Reduced 6.35%
4,766 $1.34 Million
Q1 2022

May 16, 2022

BUY
$221.42 - $260.97 $84,139 - $99,168
380 Added 8.07%
5,089 $1.33 Million
Q4 2021

Feb 14, 2022

SELL
$177.01 - $223.45 $19,117 - $24,132
-108 Reduced 2.24%
4,709 $1.03 Million
Q3 2021

Nov 12, 2021

SELL
$181.39 - $202.99 $54,598 - $61,099
-301 Reduced 5.88%
4,817 $874,000
Q2 2021

Aug 12, 2021

SELL
$187.49 - $221.1 $7,499 - $8,844
-40 Reduced 0.78%
5,118 $1.03 Million
Q1 2021

May 14, 2021

SELL
$207.02 - $241.31 $385,264 - $449,077
-1,861 Reduced 26.51%
5,158 $1.11 Million
Q4 2020

Feb 11, 2021

SELL
$207.01 - $276.09 $256,485 - $342,075
-1,239 Reduced 15.0%
7,019 $1.66 Million
Q3 2020

Nov 10, 2020

SELL
$255.65 - $303.1 $45,250 - $53,648
-177 Reduced 2.1%
8,258 $2.25 Million
Q2 2020

Aug 10, 2020

SELL
$225.48 - $295.8 $276,889 - $363,242
-1,228 Reduced 12.71%
8,435 $2.45 Million
Q1 2020

May 12, 2020

BUY
$199.77 - $247.81 $56,135 - $69,634
281 Added 3.0%
9,663 $2.32 Million
Q4 2019

Jan 24, 2020

SELL
$166.71 - $223.91 $168,710 - $226,596
-1,012 Reduced 9.74%
9,382 $2.05 Million
Q3 2019

Nov 05, 2019

SELL
$166.23 - $187.09 $281,261 - $316,556
-1,692 Reduced 14.0%
10,394 $1.76 Million
Q2 2019

Jul 18, 2019

SELL
$164.61 - $190.37 $116,379 - $134,591
-707 Reduced 5.53%
12,086 $2.22 Million
Q1 2019

Apr 18, 2019

SELL
$163.73 - $194.7 $128,855 - $153,228
-787 Reduced 5.8%
12,793 $2.35 Million
Q4 2018

Jan 25, 2019

SELL
$151.91 - $192.21 $58,789 - $74,385
-387 Reduced 2.77%
13,580 $2.25 Million
Q3 2018

Oct 17, 2018

SELL
$167.73 - $192.74 $96,612 - $111,018
-576 Reduced 3.96%
13,967 $2.56 Million
Q2 2018

Jul 27, 2018

SELL
$145.72 - $169.96 $6,265 - $7,308
-43 Reduced 0.29%
14,543 $2.47 Million
Q1 2018

Apr 06, 2018

SELL
$151.6 - $177.13 $437,062 - $510,665
-2,883 Reduced 16.5%
14,586 $2.38 Million
Q4 2017

Jan 25, 2018

BUY
$137.28 - $155.55 $491,874 - $557,335
3,583 Added 25.8%
17,469 $2.62 Million
Q3 2017

Oct 03, 2017

BUY
$148.13 - $162.24 $2.06 Million - $2.25 Million
13,886
13,886 $2.11 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Eqis Capital Management, Inc. Portfolio

Follow Eqis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.